Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Hamid Mohammadzadeh

Thoracic Surgery (Cardiothoracic Vascular Surgery) Lexington, KY Medical Doctor

NPI 1053394619 CMS profile 47341

1401 Harrodsburg Rd, Suite B-275, Lexington, KY 40504

Open in the dashboard

General payments

$18,979

214 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Hamid Mohammadzadeh of Lexington, KY is reported in the CMS Open Payments database as having received $18,979 across 214 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 79th percentile of Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $575 17
2024 General $1,047 25
2023 General $5,178 43
2022 General $2,522 34
2021 General $3,274 36
2020 General $1,450 20
2019 General $4,934 39

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Hamid Mohammadzadeh
  • Thoracic Surgery (Cardiothoracic Vascular Surgery) median
  • Middle half of Thoracic Surgery (Cardiothoracic Vascular Surgery)
  • National median

In program year 2025, general payments to Hamid Mohammadzadeh were reported at $575. Among 4,073 Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles paid that year, the median was $791 and the middle half received between $208 and $3,074.

Show as a table
Year Hamid Mohammadzadeh Thoracic Surgery (Cardiothoracic Vascular Surgery) median Middle half National median
2019 $4,934 $886 $178–$3,167 $163
2020 $1,450 $341 $108–$1,605 $114
2021 $3,274 $453 $125–$1,886 $132
2022 $2,522 $695 $180–$2,566 $149
2023 $5,178 $745 $205–$2,662 $160
2024 $1,047 $799 $214–$2,967 $164
2025 $575 $791 $208–$3,074 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Atricure, Inc. $7,915 68 payments
  2. AngioDynamics, Inc. $2,216 5 payments
  3. Edwards Lifesciences Corporation $1,799 60 payments
  4. Medical Device Business Services, Inc. $1,480 6 payments
  5. Pulmonx Corporation $1,297 4 payments
  6. Abiomed $1,255 5 payments
  7. Medtronic, Inc. $1,007 27 payments
  8. Intuitive Surgical, Inc. $671 5 payments
  9. Medtronic Vascular, Inc. $259 6 payments
  10. Silk Road Medical, Inc. $257 4 payments
  11. Other $822 24 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $8,646 192 payments
  2. Travel and Lodging $7,553 18 payments
  3. Education $1,980 2 payments
  4. Consulting Fee $800 2 payments
Products named General payments · program years 2019–2025
  1. EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX $3,934 26 payments
  2. SYNERGY ABLATION SYSTEM $2,169 14 payments
  3. EVLT $1,960 1 payment
  4. Pulmonx Endobronchial Valve EBV $1,297 4 payments
  5. Impella $1,114 3 payments
  6. AtriCure cryoICE cryoSPHERE Cryoablation System $971 8 payments
  7. Surgicel Powder $932 5 payments
  8. HARMONIC Product Family $932 5 payments
  9. ECHELON FLEX Stapler $932 5 payments
  10. ATRICLIP LAA EXCLUSION SYSTEM $748 10 payments
  11. Other $5,936 137 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

56

Median for Cardiac Surgery: 68

Drug cost

$316

Median for Cardiac Surgery: $445

Branded share of claims

100%

Median for Cardiac Surgery: 15.7%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 56 $316

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 411 Part D prescribers listed as Cardiac Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 41 billing codes

Paid by Medicare

$107,162

Medicare's payments for the services billed

Medicare patients

136

Average age 74

Services billed

277

51 women, 85 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 75%
Arthritis 49%
Heart failure 44%
Diabetes 43%
Atrial fibrillation 41%
COPD 41%
Chronic kidney disease 35%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

2 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
Kcentra
  • CSL Behring $20
$20 — —
VERQUVO
  • Merck Sharp & Dohme Corporation $15
$15 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

214 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record